NASDAQ:MASI - Masimo Stock Price, News, Headlines & Rumors

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Masimo Co. (NASDAQ:MASI) released its earnings results on Wednesday, August, 1st. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.02. The medical equipment provider had revenue of $211.62 million for the quarter, compared to the consensus estimate of $207.85 million. Masimo had a return on equity of 21.49% and a net margin of 15.30%. Masimo's quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.83 earnings per share. View Masimo's Earnings History.

Masimo is scheduled to release their next quarterly earnings announcement on Tuesday, October, 30th 2018. View Earnings Estimates for Masimo.

Masimo updated its FY18 earnings guidance on Wednesday, August, 1st. The company provided EPS guidance of $2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.89. The company issued revenue guidance of $850 million, compared to the consensus revenue estimate of $848.37 million.

4 analysts have issued 1 year price targets for Masimo's shares. Their forecasts range from $94.00 to $112.00. On average, they anticipate Masimo's share price to reach $100.75 in the next year. This suggests that the stock has a possible downside of 11.2%. View Analyst Price Targets for Masimo.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Masimo.

Masimo saw a increase in short interest in the month of July. As of July 13th, there was short interest totalling 1,398,421 shares, an increase of 71.7% from the June 29th total of 814,473 shares. Based on an average daily trading volume, of 489,980 shares, the days-to-cover ratio is presently 2.9 days. Approximately 2.9% of the company's stock are sold short. View Masimo's Current Options Chain.

Some companies that are related to Masimo include SONOVA Hldg AG/ADR (SONVY), Varian Medical Systems (VAR), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen, Inc Common Stock (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), electroCore (ECOR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Vision Sciences (CGNT) and Helius Medical Technologies (HSDT).

News headlines about MASI stock have trended positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Masimo earned a news and rumor sentiment score of 0.35 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 51.68 out of 100, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next several days. View Recent Headlines for Masimo.

Masimo's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.04%), FMR LLC (3.52%), Schroder Investment Management Group (1.54%), Point72 Asset Management L.P. (1.43%), Bank of New York Mellon Corp (1.21%) and Renaissance Technologies LLC (1.07%). Company insiders that own Masimo stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

MASI stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Voya Investment Management LLC, American Century Companies Inc., Acadian Asset Management LLC, Morgan Stanley, Canada Pension Plan Investment Board and Bank of New York Mellon Corp. Company insiders that have sold Masimo company stock in the last year include Joe E Kiani, Jon Coleman, Ramshorst David J Van, Sanford Fitch, Steven Barker and Yongsam Lee. View Insider Buying and Selling for Masimo.

MASI stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Schroder Investment Management Group, Caisse DE Depot ET Placement DU Quebec, Marshall Wace LLP, First Quadrant L P CA, Frontier Capital Management Co. LLC, Bank of Nova Scotia and Paloma Partners Management Co. View Insider Buying and Selling for Masimo.

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MASI stock can currently be purchased for approximately $113.52.

Masimo has a market capitalization of $5.68 billion and generates $798.11 million in revenue each year. The medical equipment provider earns $131.61 million in net income (profit) each year or $2.45 on an earnings per share basis. Masimo employs 1,400 workers across the globe.

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]